Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve Eyes | Zendy

Mark C. Gillies | Zendy; Richard Walton | Zendy; Judy M. Simpson | Zendy; Jennifer Arnold | Zendy; Robyn H. Guymer | Zendy; Ian L. McAllister | Zendy; Alex P. Hunyor | Zendy; Rohan W. Essex | Zendy; Nigel Morlet | Zendy; Daniel Barthelmes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve Eyes

Author(s) -

Mark C. Gillies,

Richard Walton,

Judy M. Simpson,

Jennifer Arnold,

Robyn H. Guymer,

Ian L. McAllister,

Alex P. Hunyor,

Rohan W. Essex,

Nigel Morlet,

Daniel Barthelmes

Publication year - 2013

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.13-11993

Subject(s) - medicine , macular degeneration , confidence interval , ophthalmology , visual acuity , endophthalmitis , prospective cohort study , lesion , cohort , cohort study , exudative age related macular degeneration , surgery

We report the 12-month outcomes of 1140 treatment-naïve eyes with exudative age-related macular degeneration (wet AMD) who were treated for 12 months with intravitreal anti-VEGF drugs in routine clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research